This grant proposal is being submitted to obtain funding for the University of Virginia Digestive Health Research Center (UVa DHRC). The Center's major theme is the molecular and cellular mechanisms involved in the pathogenesis of gastrointestinal inflammation and cancer. The UVa DHRC is a multidisciplinary program, including members in 12 different academic departments with 46 investigators (34 full members and 12 associate members). The major objective of the UVa DHRC is to promote digestive health related research in an integrated, collaborative, and multi-disciplinary fashion. In order to accomplish this goal, the proposed UVa DHRC will: 1) enhance the basic research capabilities of Center members, 2) develop and implement programs to support the independent development of young investigators in digestive health related research, 3) attract established investigators with varied expertise who are not currently involved in digestive health research to apply their expertise to this important area of investigation, and 4) facilitate the translation of basic research discoveries to the clinical arena. We have strong institutional support to increase the impact of digestive health research at the University of Virginia through the development of a UVa DHRC. The proposed UVa DHRC is organized around 3 broad thematic areas of research: 1) mucosal immunology/intestinal inflammation, 2) gastrointestinal host-microbial interactions, and 3) epithelial cell biology/tumorigenesis. The Research Base for the Center consists of $13.2 million, with 52% of these funds coming from the NIDDK. We are proposing 3 scientific cores to support this Research Base: 1) a Morphology/Imaging Core, 2) a Molecular Biology/Gene Expression Core, and 3) an Immunology/Cell Isolation Core. These core laboratories interface with a well-organized Administrative Core, which also supports Pilot/Feasibility and Named New Investigator Programs to support innovative research projects by investigators who are new to the area of digestive health. The Administrative Core also includes an Enrichment Program and a Translational Research Component, and oversees the financial management and operation of the UVa DHRC. The overall objective of the UVA DHRC is to increase the availability of core resources for Center members, with the goal of fostering research, collaborations, and new directions in digestive and liver disease research.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-8 (J1))
Program Officer
Podskalny, Judith M,
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Virginia
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Del Pinto, Rita; Pietropaoli, Davide; Chandar, Apoorva K et al. (2015) Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis. Inflamm Bowel Dis 21:2708-17
Das, Soumita; Sarkar, Arup; Ryan, Kieran A et al. (2014) Brain angiogenesis inhibitor 1 is expressed by gastric phagocytes during infection with Helicobacter pylori and mediates the recognition and engulfment of human apoptotic gastric epithelial cells. FASEB J 28:2214-24
Wilson, Jeffrey M; Kurtz, Courtney C; Black, Steven G et al. (2011) The A2B adenosine receptor promotes Th17 differentiation via stimulation of dendritic cell IL-6. J Immunol 186:6746-52
Sokolowski, Jennifer D; Nobles, Suzanne L; Heffron, Daniel S et al. (2011) Brain-specific angiogenesis inhibitor-1 expression in astrocytes and neurons: implications for its dual function as an apoptotic engulfment receptor. Brain Behav Immun 25:915-21
Morris, Margaret A; McDuffie, Marcia; Nadler, Jerry L et al. (2011) Prevention, but not cure, of autoimmune diabetes in a NOD.scid transfer model by FTY720 despite effective modulation of blood T cells. Autoimmunity 44:115-28
Sabri, Saher S; Swee, Warren; Turba, Ulku C et al. (2011) Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. J Vasc Interv Radiol 22:309-16; quiz 316
Armstrong, Allison; Ravichandran, Kodi S (2011) Phosphatidylserine receptors: what is the new RAGE? EMBO Rep 12:287-8
Tacke, Robert S; Tosello-Trampont, Annie; Nguyen, Virginia et al. (2011) Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway. J Biol Chem 286:10847-55
Preidis, Geoffrey A; Hill, Colin; Guerrant, Richard L et al. (2011) Probiotics, enteric and diarrheal diseases, and global health. Gastroenterology 140:8-14
Ballard, T Eric; Wang, Xia; Olekhnovich, Igor et al. (2011) Synthesis and antimicrobial evaluation of nitazoxanide-based analogues: identification of selective and broad spectrum activity. ChemMedChem 6:362-77

Showing the most recent 10 out of 239 publications